Studies show that more than a fifth of the global population, mostly in low- and middle-income countries, may have to wait until at least 2022 to receive a COVID-19 vaccine.
List view / Grid view
Johns Hopkins Bloomberg School of Public Health
Filter the results
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
A study has found that the FDA failed to design and implement an effective monitoring program for Transmucosal Immediate-Release Fentanyls...
"The key message of this paper is that to do the best by all our children and to help them survive, all countries should introduce rotavirus vaccination.”
15 May 2017 | By Niamh Marriott, Junior Editor
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the US...